Terms: = Liver cancer AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Diagnosis
22 results:
1. Real-world evidence of the safety and survival with CD19 car-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
McKenna M; Epperla N; Ghobadi A; Liu J; Lazaryan A; Ibrahim U; Jacobson CA; Naik SG; Nastoupil L; Chowdhury SM; Voorhees TJ; Jacobs MT; Farooq U; Osman K; Olszewski AJ; Ahmed S; Evens AM
Br J Haematol; 2023 Jul; 202(2):248-255. PubMed ID: 37129856
[TBL] [Abstract] [Full Text] [Related]
2. Acquired crizotinib-resistant pulmonary adenocarcinoma and subsequent primary gallbladder cancer: A case report.
Zhang M; Chen R; Zheng S; Wang Z
Medicine (Baltimore); 2023 Mar; 102(11):e33162. PubMed ID: 36930086
[TBL] [Abstract] [Full Text] [Related]
3. Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation.
Odedra D; Jandaghi AB; Bhayana R; Elbanna KY; Espin-Garcia O; Fischer SE; Ghanekar A; Sapisochin G; Jhaveri KS
Cancer Imaging; 2022 Oct; 22(1):55. PubMed ID: 36195953
[TBL] [Abstract] [Full Text] [Related]
4. ALK Translocation in ALK-Positive Mesenchymal Tumors: Diagnostic and Therapeutic Insights.
Jung M; Moon KC; Bae J; Kim TM; Kim M; Jeon YK; Lee C
Arch Pathol Lab Med; 2022 Dec; 146(12):1460-1470. PubMed ID: 35438749
[TBL] [Abstract] [Full Text] [Related]
5. The Landscape Of Alpha Fetoprotein In Hepatocellular carcinoma: Where Are We?
Hu X; Chen R; Wei Q; Xu X
Int J Biol Sci; 2022; 18(2):536-551. PubMed ID: 35002508
[TBL] [Abstract] [Full Text] [Related]
6. [Management of cytokine release syndrome and macrophage activation syndrome following car-T cell therapy: Guidelines from the SFGM-TC].
Tudesq JJ; Yakoub-Agha M; Bay JO; Courbon C; Paul F; Picard M; Pochon C; Sterin A; Vicente C; Canet E; Yakoub-Agha I; Moreau AS
Bull Cancer; 2023 Feb; 110(2S):S116-S122. PubMed ID: 34895696
[TBL] [Abstract] [Full Text] [Related]
7. Advanced HCC Patient Benefit From Neoantigen Reactive T Cells Based Immunotherapy: A Case Report.
Liu C; Shao J; Dong Y; Xu Q; Zou Z; Chen F; Yan J; Liu J; Li S; Liu B; Shen J
Front Immunol; 2021; 12():685126. PubMed ID: 34326839
[TBL] [Abstract] [Full Text] [Related]
8. Assessment of Textbook Outcome in Laparoscopic and Open liver Surgery.
Görgec B; Benedetti Cacciaguerra A; Lanari J; Russolillo N; Cipriani F; Aghayan D; Zimmitti G; Efanov M; Alseidi A; Mocchegiani F; Giuliante F; Ruzzenente A; Rotellar F; Fuks D; D'Hondt M; Vivarelli M; Edwin B; Aldrighetti LA; Ferrero A; Cillo U; Besselink MG; Abu Hilal M
JAMA Surg; 2021 Aug; 156(8):e212064. PubMed ID: 34076671
[TBL] [Abstract] [Full Text] [Related]
9. cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract] [Full Text] [Related]
10. The tumor microenvironment of colorectal cancer metastases: opportunities in cancer immunotherapy.
Kamal Y; Schmit SL; Frost HR; Amos CI
Immunotherapy; 2020 Oct; 12(14):1083-1100. PubMed ID: 32787587
[TBL] [Abstract] [Full Text] [Related]
11. The utility of flow cytometry in the diagnostic work up of malignant effusions due to nonhematopoietic neoplasms.
Wong-Arteta J; Rey M; Aragón L; Gil-Rodríguez E; Bujanda L
Cytometry B Clin Cytom; 2020 Nov; 98(6):504-515. PubMed ID: 32506689
[TBL] [Abstract] [Full Text] [Related]
12. Wnt/β-catenin signaling as an emerging potential key pharmacological target in cholangiocarcinoma.
Zhang GF; Qiu L; Yang SL; Wu JC; Liu TJ
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32140709
[TBL] [Abstract] [Full Text] [Related]
13. cancer-associated retinopathy in ampullary pancreatic cancer.
Ghadiri N; Yang Y; Burton BJ
BMJ Case Rep; 2019 Nov; 12(11):. PubMed ID: 31712238
[TBL] [Abstract] [Full Text] [Related]
14. diagnosis and Management of Immune Related Adverse Events (irAEs) in cancer Immunotherapy.
Liu YH; Zang XY; Wang JC; Huang SS; Xu J; Zhang P
Biomed Pharmacother; 2019 Dec; 120():109437. PubMed ID: 31590992
[TBL] [Abstract] [Full Text] [Related]
15. Clinical immunology and immunotherapy for hepatocellular carcinoma: current progress and challenges.
Wang L; Wang FS
Hepatol Int; 2019 Sep; 13(5):521-533. PubMed ID: 31352593
[TBL] [Abstract] [Full Text] [Related]
16. prkar1a overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group.
Loilome W; Yooyuen S; Namwat N; Sithithaworn P; Puapairoj A; Kano J; Noguchi M; Miwa M; Yongvanit P
Tumour Biol; 2012 Dec; 33(6):2289-98. PubMed ID: 22922884
[TBL] [Abstract] [Full Text] [Related]
17. [Etiopathological factors of hepatocellular carcinoma in Bangui, Central African Republic: clinical, biological characteristics and virological aspects of patients].
Bekondi C; Mobima T; Ouavènè JO; Koffi B; Konamna X; Béré A; Le Faou A
Pathol Biol (Paris); 2010 Apr; 58(2):152-5. PubMed ID: 19875248
[TBL] [Abstract] [Full Text] [Related]
18. Late liver metastases of choroidal melanoma detected by laparoscopy.
Orlando R; Lumachi F
In Vivo; 2008; 22(6):807-9. PubMed ID: 19181011
[TBL] [Abstract] [Full Text] [Related]
19. A novel prkar1a mutation associated with hepatocellular carcinoma in a young patient and a variable carney complex phenotype in affected subjects in older generations.
Gennari M; Stratakis CA; Hovarth A; Pirazzoli P; Cicognani A
Clin Endocrinol (Oxf); 2008 Nov; 69(5):751-5. PubMed ID: 18445140
[TBL] [Abstract] [Full Text] [Related]
20. Efficiency of MR imaging in the detection of malignant liver lesions.
Obuz F; Oksüzler M; Seçil M; Sağol O; Karademir S; Astarcioğlu H
Diagn Interv Radiol; 2006 Mar; 12(1):17-21. PubMed ID: 16538579
[TBL] [Abstract] [Full Text] [Related]
[Next]
